ENVARRIO
LIVE

Serial Number

79133201

Owner

VELOXIS PHARMACEUTICALS A/S

Filing Date

Feb 7, 2013

Add to watchlist:

No watchlists yet
View on USPTO

ENVARRIO Trademark

Serial Number: 79133201 • Registration: 4457208

ENVARRIO is a trademark filed by VELOXIS PHARMACEUTICALS A/S on February 7, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

VELOXIS PHARMACEUTICALS A/S (27 trademarks)

KOGLE ALLE 4
DK-2970 HORSHOLM , DK

Entity Type: 99

Veloxis Pharmaceuticals, Inc. (12 trademarks)

2000 Regency Parkway,

Entity Type: 99

Trademark Details

Filing Date

February 7, 2013

Registration Date

December 31, 2013

Published for Opposition

October 15, 2013

Cancellation Date

February 7, 2023

Goods & Services

Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries

Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, granules, pills, sachets, powders, capsules, all of the above for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy and immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalised pain

Medical services; medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals

Scientific and technological services, namely, clinical testing and technology transfer services as well as research and design in connection therewith, namely, within the medical, pharmaceutical, biotechnical and bacteriological areas and providing scientific consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sep 2, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Sep 2, 2023 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Apr 3, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 24, 2022 INTS
INVALIDATION PROCESSED
Feb 23, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CHANGE OF OWNER RECEIVED FROM IB
Sep 18, 2021 CHLD
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 21, 2021 ADCH
CANCELLED SECTION 71
Feb 26, 2021 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2020 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 31, 2018 REM3
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 19, 2018 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 3, 2018 CRCV
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 18, 2018 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jul 21, 2016 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 26, 2015 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 20, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 30, 2014 FICS
FINAL DISPOSITION PROCESSED
May 30, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 31, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Oct 15, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2013 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 25, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 25, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 11, 2013 PREV
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2013 CRFA
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 10, 2013 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 6, 2013 CRCV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2013 CRFA
ASSIGNED TO LIE
Aug 29, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2013 TROA
REFUSAL PROCESSED BY IB
Aug 24, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 2, 2013 RFCS
REFUSAL PROCESSED BY MPU
Aug 2, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 2, 2013 RFCR
NON-FINAL ACTION WRITTEN
Aug 1, 2013 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 31, 2013 MAFR
ASSIGNED TO EXAMINER
Jul 27, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 26, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 25, 2013 REPR